Authors : Shruti Gupta; Arti Modanwal; Awan Kumar Pandey

Volume/Issue : Volume 10 - 2025, Issue 4 - April

---

Google Scholar : https://tinyurl.com/52bkvfkp

Scribd : https://tinyurl.com/ys4unnzp

DOI : https://doi.org/10.38124/ijisrt/25apr1210

Google Scholar

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Note : Google Scholar may take 15 to 20 days to display the article.

---

Abstract : The empirical practice of using particular food types to ease stomach discomfort has long demonstrated the impact of diet on gut health, and more recently, a link has been found between particular diets and decreased rates of a number of gastrointestinal disorders. Some of the herbal medicines, derived from traditional medical systems such as Ayurveda, Traditional Chinese Medicine, and Western herbalism, offer a promising alternative due to their multi-targeted therapeutic actions and favourable safety profiles. In order to provide evidence-based recommendations for the consumption of these products, we have reviewed recent research on these food-derived ingredients and their suggested preventive and therapeutic roles in gastrointestinal disorders.

References :

1. Spiller RC. Irritable bowel syndrome. Br Med Bull 2004; 72: 15-29
2. Cremonini F, Talley NJ. Irritable bowel syndrome: epidemiology, natural history, health care seeking and emerging risk factors. Gastroenterol Clin North Am 2005; 34: 189-204
3. Gwee KA. Irritable bowel syndrome in developing countries--a disorder of civilization or colonization? Neurogastroenterol Motil 2005; 17: 317-324
4. Spanier JA, Howden CW, Jones MP. A systematic review of alternative therapies in the irritable bowel syndrome. Arch Intern Med 2003; 163: 265-274
5. Thompson WG, Greed FH, Drossman DA, Heaton KW, Mazzacca G. Functional bowel disorders and functional abdominal pain. Gastroenterology International 1992; 5: 75-91
6. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45 Suppl 2: II43-II47
7. National Symposium on Chronic Diarrhea. The Diagnostic Criteria for Irritable Bowel Syndrome. Zhonghua Xiaohuabin Zazhi 1987; 7: inside back cover
8. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 1996; 17: 1-12
9. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 [updated September 2006]. In: The Cochrane Library, Issue 4, 2006. Chichester, UK: John Wiley & Sons, Ltd. Available from: URL: http//www. cochrane.org/resources/handbook:79-87
10. Gao ZJ, Zeng XZ. 72 Cases Clinical Observations on the Treatment of Irritable Bowel Syndrome with Chinese Medicine. Hunan Zhongyi Zazhi 1992; 4: 10-11
11. Bensoussan A, Talley NJ, Hing M, Menzies R, Guo A, Ngu M. Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial. JAMA 1998; 280: 1585-1589
12. Zhao LJ, Li SL, Song SY, Xu DQ, Qin YS. A Contrastive Observation in Treatment of 223 patients Diarrhea-Predominant Irritable Bowel Syndrome between Chinese Medicine and Western Medicine. Henan Zhongyi 2000; 20: 35
13. Lei CF, Chu LZ. Treatment Irritable Bowel Syndrome Based on ‘Tang’ in 48 patients. Shandong Zhongyi Zazhi 2000; 19: 206
14. Wang ZH. Clinical Effect of Geginshujiangshaocaotang on Irritable Bowel Syndrome. Hebei Zhongyi 2000; 22: 738-739
15. Ye B, Shan ZW. Clinical Study of Xianshi Capsule for Irritable Bowel Syndrome. Nanjing Zhongyiyao Daxue Xuebao 2002; 18: 273-274
16. Dang ZM, Yang Q. Clinical Observation of Huanchang decoction in 32 patents with Irritable Bowel Syndrome. Anhui Zhongyi Linchuang Zazhi 2002; 14: 113-114
17. Zeng BM. Treatment of 50 patients with irritable Bowel Syndrome Based on Pi. Sichuan Zhongyi 2002; 20: 39-40
18. Ge W. Treatment of Irritable Bowel Syndrome with a traditional Chinese Medicine‘Xiangsha Liujunzi decoction’. Hubei Zhongyi Zazhi 2002; 24: 34
19. Zhou FS, Wu WJ, Huang ZX. Effect of Shunji mixture in Treating Irritable Bowel Syndrome. Guangzhou Zhongyiyao Daxue Xuebao 2002; 19: 269-270
20. Sallon S, Ben-Arye E, Davidson R, Shapiro H, Ginsberg G, Ligumsky M. A novel treatment for constipation-predominant irritable bowel syndrome using Padma Lax, a Tibetan herbal formula. Digestion 2002; 65: 161-171
21. Ma BH, Zhou T. Observation of therapeutic effect of Changkang Capsule for Treatment of 120 patients Irritable Bowel Syndrome. Zhongyiyao Xuekan 2003; 21: 1748, 1779
22. Wang JH, Tian XD, Dong SX. Wuma Simo decoction for Treating 52 patients of Irritable Bowel Syndrome. Shiyong Yiji Zazhi 2003; 10: 686
23. Liu Q, Lin Y, Xu LT. Clinical Study on Gegen Qinlian pellet for Irritable Bowel Syndrome Comparing with Nifedipine. Shiyong Zhongxiyi Jiehe Linchuang 2003; 3: 9
24. Li FL, Cao ZC, Zhang YS. Observation of Therapeutic Effect of Changning Yin decoction for Treatment Irritable Bowel Syndrome. Zhongguo Zhongyiyao Keji 2003; 10: 334
25. Shen Y, Cai G, Sun X, Zhao HL. Randomized Controlled Clinical Study on Effect of Chinese Compound Changjitai in Treating Diarrheic Irritable Bowel Syndrome. Zhongguo Zhongxiyi Jiehe Zazhi 2003; 23: 823-825
26. Zhao LY, Chu HM. To Observe the Clinical effects of Liyiting in the Treatment of Irritable Bowel Syndrome of Diarrhea Pattern. Shanghai Zhongyiyao Zazhi 2004; 38: 22-23 Shi J et al. Herbal medicines and IBS 461
27. Alammar N, Wang L, Saberi B, Nanavati J, Holtmann G, Shinohara RT, et al. The impact of peppermint oil on the irritable bowel syn-drome: a meta-analysis of the pooled clinical data. BMC Complement Altern Med. 2019 Jan;19(1):21.
28. Rich G, Shah A, Koloski N, Funk P, Stracke B, Köhler S, et al. A randomized placebo-con-trolled trial on the effects of Menthacarin, a proprietary peppermint- and caraway-oil-preparation, on symptoms and quality of life in patients with functional dyspepsia. Neuro-gastroenterol Motil. 2017 Nov;29(11):e13132.
29. Koloski NA, Talley NJ, Huskic SS, Boyce PM. Predictors of conventional and alternative health care seeking for irritable bowel syn-drome and functional dyspepsia. Aliment Pharmacol Ther. 2003 Mar;17(6):841–51. 30 Burgmann T, Rawsthorne P, Bernstein CN.
30. Peery AF, Dellon ES, Lund J, Crockett SD, McGowan CE, Bulsiewicz WJ, et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology. 2012 Nov;143(5):1179–1187.e3.
31. Vu J, Kushnir V, Cassell B, Gyawali CP, Sayuk GS. The impact of psychiatric and extraintes-tinal comorbidity on quality of life and bowel symptom burden in functional GI disorders. Neurogastroenterol Motil. 2014 Sep;26(9):1323–32.
32. Cash BD, Sullivan D, Barghout V. Total costs of IBS: employer and managed care perspective. Am J Manag Care. 2005 Apr;11(1 Suppl):S7–16.34 Buono JL, Carson RT, Flores NM. Health-re-lated quality of life, work productivity, and in-direct costs among patients with irritable bowel syndrome with diarrhea. Health Qual Life Outcomes. 2017 Feb